About this trial
Background:
\- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number and the type of bacteria on the skin.
Objectives:
\- To study the effect of eczema treatments on skin bacteria.
Eligibility:
* Individuals between 2 and 25 years of age who have moderate to severe atopic dermatitis. * Healthy volunteers between 18 and 40 years of age with no history of eczema.
Design:
* Participants will be screened with a physical exam and medical history. Research samples will be collected. Skin biopsies may also be performed. * All participants will be assigned to one of several study groups. * Healthy volunteers must not have taken antibiotics in the year before the start of the study. * All participants will have regular study visits during their 1-year participation. More research samples will be collected at these visits. * Healthy volunteers may be asked to come in for a one-time follow up after the 1 year mark.
Eligibility criteria
Qualifiers
Males and females aged 18-50 years at time of initial protocol sampling
Subjects must participate fully and be willing to comply with the procedures of the protocol
Subjects must be co-enrolled in NIH protocol 08-HG-0059
Ability of subject to understand and provide written informed consent
Disqualifiers
Does not meet inclusion criteria
Any female with symptoms and/or serum hormone levels consistent with perimenopause or menopause
Use of systemic antibiotics in 12 months preceding baseline sampling
Use of swimming pools, hot tubs, or whirlpools in 7 days preceding baseline sampling
Trial design
Treatments tested in this trial
- Trimethoprim/sulfamethoxazole (TMP/SMZ)
- Cephalexin
- Doxycycline
- Sodium hypochlorite
- Placebo capsules
- Placebo Sodium hypochlorite
Treatment groups
10
Treatment groupsSee each treatment group below.